Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,063 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial.
Gu W, Han W, Luo H, Zhou F, He D, Ma L, Guo H, Liang C, Chong T, Jiang J, Chen Z, Wang Y, Zou Q, Tian Y, Xiao J, Huang J, Zhu S, Dong Q, Zhang X, Li H, Yang X, Chen C, Li J, Jin C, Zhang X, Ye D; CHART Investigators. Gu W, et al. Among authors: zhou f. Lancet Oncol. 2022 Oct;23(10):1249-1260. doi: 10.1016/S1470-2045(22)00507-1. Epub 2022 Sep 5. Lancet Oncol. 2022. PMID: 36075260 Clinical Trial.
A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.
Lin X, Qu L, Chen Z, Xu C, Ye D, Shao Q, Wang X, Qi J, Chen Z, Zhou F, Wang M, Wang Z, He D, Wu D, Gao X, Yuan J, Wang G, Xu Y, Wang G, Dong P, Jiao Y, Yang J, Ou-Yang J, Jiang H, Zhu Y, Ren S, Zhang Z, Yin C, Wu Q, Zheng Y, Turner AR, Tao S, Na R, Ding Q, Lu D, Shi R, Sun J, Liu F, Zheng SL, Mo Z, Sun Y, Xu J. Lin X, et al. Among authors: zhou f. Prostate. 2013 Jan;73(2):169-75. doi: 10.1002/pros.22552. Epub 2012 Jun 21. Prostate. 2013. PMID: 22718278 Free PMC article. Clinical Trial.
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.
Xu J, Mo Z, Ye D, Wang M, Liu F, Jin G, Xu C, Wang X, Shao Q, Chen Z, Tao Z, Qi J, Zhou F, Wang Z, Fu Y, He D, Wei Q, Guo J, Wu D, Gao X, Yuan J, Wang G, Xu Y, Wang G, Yao H, Dong P, Jiao Y, Shen M, Yang J, Ou-Yang J, Jiang H, Zhu Y, Ren S, Zhang Z, Yin C, Gao X, Dai B, Hu Z, Yang Y, Wu Q, Chen H, Peng P, Zheng Y, Zheng X, Xiang Y, Long J, Gong J, Na R, Lin X, Yu H, Wang Z, Tao S, Feng J, Sun J, Liu W, Hsing A, Rao J, Ding Q, Wiklund F, Gronberg H, Shu XO, Zheng W, Shen H, Jin L, Shi R, Lu D, Zhang X, Sun J, Zheng SL, Sun Y. Xu J, et al. Among authors: zhou f. Nat Genet. 2012 Nov;44(11):1231-5. doi: 10.1038/ng.2424. Epub 2012 Sep 30. Nat Genet. 2012. PMID: 23023329 Free PMC article.
Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.
Na R, Liu F, Zhang P, Ye D, Xu C, Shao Q, Qi J, Wang X, Chen Z, Wang M, He D, Wang Z, Zhou F, Yuan J, Gao X, Wei Q, Yang J, Jiao Y, Ou-Yang J, Zhu Y, Wu Q, Chen H, Lu D, Shi R, Lin X, Jiang H, Wang Z, Jiang D, Sun J, Zheng SL, Ding Q, Mo Z, Sun Y, Xu J. Na R, et al. Among authors: zhou f. Prostate. 2013 Nov;73(15):1623-35. doi: 10.1002/pros.22629. Epub 2013 Sep 9. Prostate. 2013. PMID: 24038036 Free PMC article.
A multicenter, randomized clinical trial comparing the three-weekly docetaxel regimen plus prednisone versus mitoxantone plus prednisone for Chinese patients with metastatic castration refractory prostate cancer.
Zhou T, Zeng SX, Ye DW, Wei Q, Zhang X, Huang YR, Ye ZQ, Yang Y, Zhang W, Tian Y, Zhou FJ, Jie J, Chen SP, Sun Y, Xie LP, Yao X, Na YQ, Sun YH. Zhou T, et al. PLoS One. 2015 Jan 27;10(1):e0117002. doi: 10.1371/journal.pone.0117002. eCollection 2015. PLoS One. 2015. PMID: 25625938 Free PMC article. Clinical Trial.
Chinese guidelines on the management of renal cell carcinoma (2015 edition).
Guo J, Ma J, Sun Y, Qin S, Ye D, Zhou F, He Z, Sheng X, Bi F, Cao D, Chen Y, Huang Y, Liang H, Liang J, Liu J, Liu W, Pan Y, Shu Y, Song X, Wang W, Wang X, Wu X, Xie X, Yao X, Yu S, Zhang Y, Zhou A; written on behalf of CSCO Renal Cell Carcinoma Committee. Guo J, et al. Among authors: zhou f, zhou a. Chin Clin Oncol. 2016 Feb;5(1):12. doi: 10.3978/j.issn.2304-3865.2015.11.01. Chin Clin Oncol. 2016. PMID: 26932436 Free article. No abstract available.
Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium.
Lin T, Li K, Liu H, Xue X, Xu N, Wei Y, Chen Z, Zhou X, Qi L, He W, Tong S, Jin F, Liu X, Wei Q, Han P, Gou X, He W, Zhang X, Yang G, Shen Z, Xu T, Xie X, Xue W, Cao M, Yang J, Hu J, Chen F, Li P, Li G, Xu T, Tian Y, Wang W, Song D, Shi L, Yang X, Yang Y, Shi B, Zhu Y, Liu X, Xing J, Wu Z, Zhang K, Li W, Liang C, Yang C, Li W, Qi J, Xu C, Xu W, Zhou L, Cai L, Xu E, Cai W, Weng M, Su Y, Zhou F, Jiang L, Liu Z, Chen Q, Pan T, Liu B, Zhou Y, Gao X, Qiu J, Situ J, Hu C, Chen S, Zheng Y, Huang J. Lin T, et al. Among authors: zhou x, zhou y, zhou f, zhou l. World J Urol. 2018 Jan;36(1):41-50. doi: 10.1007/s00345-017-2108-3. Epub 2017 Oct 28. World J Urol. 2018. PMID: 29080948 Clinical Trial.
Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database.
Li K, Lin T; Chinese Bladder Cancer Consortium; Xue W, Mu X, Xu E, Yang X, Chen F, Li G, Ma L, Wang G, Liang C, Shi H, Li M, Tang M, Xue X, Lv Y, Deng Y, Li C, Chen Z, Zhou X, Jin F, Liu X, Wei J, Shi L, Gou X, He W, Zhou L, Cai L, Jin B, Fu G, Kong X, Sun H, Tian Y, Feng L, Pan T, Wu Y, Wang D, Hao H, Shi B, Zhu Y, Wei Q, Han P, Wu C, Tian D, Ye Z, Liu Z, Wang Z, Tian J, Qi L, Chen M, Li W, Qi J, Wang G, Fu L, Sun Z, Luo G, Shen Z, Zhu Z, Xing J, Wu Z, Wei D, Chen X, Na Y, Guo H, Wang C, Lu Z, Kong C, Liu Y, Yang J, Hu J, Gao X, Li J, Yin C, Li P, Chen S, Du Z, Li J, Yan Y, Zhang X, Huang S, Zhou F, Zhang Z, Sun Y, Zeng S, Cen S, Zhou J, Li H, Wen J, Huang J. Li K, et al. Among authors: zhou x, zhou j, zhou f, zhou l. Asian J Urol. 2015 Apr;2(2):63-69. doi: 10.1016/j.ajur.2015.04.016. Epub 2015 Apr 16. Asian J Urol. 2015. PMID: 29264122 Free PMC article.
A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia.
Ye D, Huang Y, Zhou F, Xie K, Matveev V, Li C, Alexeev B, Tian Y, Qiu M, Li H, Zhou T, De Porre P, Yu M, Naini V, Liang H, Wu Z, Sun Y. Ye D, et al. Among authors: zhou t, zhou f. Asian J Urol. 2017 Apr;4(2):75-85. doi: 10.1016/j.ajur.2017.01.002. Epub 2017 Jan 23. Asian J Urol. 2017. PMID: 29264210 Free PMC article.
10,063 results
You have reached the last available page of results. Please see the User Guide for more information.